CHICAGO -- Researchers failed to prevent cognitive impairment in people with existing atrial fibrillation (Afib) by going the ...

The company uses a novel machine learning algorithm, IntelliSense AFib, to analyze pressure pulse waves generated during ...

Prescribing anti-clotting medications to adults younger than age 65 who have atrial fibrillation (AFib) but no other risk ...

Share on PinterestNew research suggests that there may be more than 10.5 million people in the United States living with ...

AFib is the most common type of irregular heart rhythm in the U.S., and blood thinners, also known as anti-clotting ...

In the first large trial of its kind, the anti-clotting medication rivaroxaban did not lower the risk of cognitive decline ...

The REACT-AF trial began in July 2023 and is led by researchers at Johns Hopkins Medicine. Randomized patients (half of the ...

The study, led by New York University Langone Health researchers who looked at data from more than 6,000 Fitbit users who ...

The FDA has granted a de novo clearance to a wearable device—with a form factor you’re familiar with—that can check patients ...

In a pivotal stride to address the growing AFib epidemic, OMRON Healthcare today announced the U.S. Food and Drug ...

OMRON Healthcare has secured De Novo authorisation from the US Food and Drug Administration (FDA) for new home blood pressure ...

New research indicates that 1 hour of moderate exercise per week can help prevent atrial fibrillation (AFib). While a small ...